TPD52 is a prognostic biomarker and potential therapeutic target for ER+/PR+/HER2+ breast cancer
@article{CCO125076,
author = {Xiaolin Cheng and Zhengdong Li and Xiaoqing Jia and Zhiyuan Fan and Qizhi He and Zhigang Zhuang},
title = {TPD52 is a prognostic biomarker and potential therapeutic target for ER+/PR+/HER2+ breast cancer},
journal = {Chinese Clinical Oncology},
volume = {13},
number = {3},
year = {2024},
keywords = {},
abstract = {},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/125076}
}